Swiss National Bank’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Swiss National Bank’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-64,500	Closed	-$2.15M	–	2502
2024 Q3	$2.15M	Buy	64,500 +8,300	+15%	+$286K	﹤0.01%	1825
2024 Q2	$1.52M	Buy	56,200 +13,900	+33%	+$274K	﹤0.01%	1952
2024 Q1	$914K	Buy	+42,300	New	+$922K	﹤0.01%	2265

Swiss National Bank's LBPH Position: Q4 2024 in Review

Swiss National Bank sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 64,500 shares — an estimated $2.15M sold.

Swiss National Bank first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $2.15M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Swiss National Bank reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Swiss National Bank sold 64,500 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $2.15M.
Swiss National Bank first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Swiss National Bank's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $2.15M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Swiss National Bank's 13F filing for Q4 2024, filed 10 Feb 2025.